Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, im going to discuss my 3 mistakes and what I learned from them.

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
28 Nov 2025, 01:28 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, im going to discuss my 3 mistakes and what I learned from them.
Source overview

AI-generated source summary

The analysis identifies 3 mistakes in financial investments. First one is related with WBD, bought in late 2022. The video shares a personal experience of loss, attributable to merger between Warner Bros and Discovery, leading to a 27% loss when exiting the position around $21-$22. The fundamental reasoning based on pro forma revenue numbers was flawed because Warner Brothers numbers were wrong. The mistake in early 2023 was to trust over the CFO numbers. The presenter advises retail investors to avoid pre-merger investment setups. Second mistake relates to selling apple stock and also the risk of not buying stocks during the dip. The presenter advice in general to trim the portion and not sell everything.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.2
Tracked signals
327
Historical success
33.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail